Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.

Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.

Item
http://www.wikidata.org/entity/Q49218199
Dimensionality of carbon nanomaterials determines the binding and dynamics of amyloidogenic peptides: multiscale theoretical simulationsEffects of hydroxylated carbon nanotubes on the aggregation of Aβ16-22 peptides: a combined simulation and experimental study.Effect of intra-membrane C60 fullerenes on the modulus of elasticity and the mechanical resistance of gel and fluid lipid bilayers.The interplay between carbon nanomaterials and amyloid fibrils in bio-nanotechnology.Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design.The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragment.Molecular dynamics simulation studies of the structural response of an isolated Aβ1-42 monomer localized in the vicinity of the hydrophilic TiO 2 surface.The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.Binding of fullerenes to amyloid beta fibrils: size matters.Unraveling origins of the heterogeneous curvature dependence of polypeptide interactions with carbon nanostructures.Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4′ benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulationsInhibitory effect of hydrophobic fullerenes on the β-sheet-rich oligomers of a hydrophilic GNNQQNY peptide revealed by atomistic simulations
P2860

Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.

Item
http://www.wikidata.org/entity/Q49218199
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@nl
type
label
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@nl
prefLabel
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921